Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 28, 2012; 18(40): 5753-5758
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5753
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5753
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
Kazue Shiozawa, Manabu Watanabe, Yoshinori Kikuchi, Yasukiyo Sumino, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Medical Center, Omori Hospital, Tokyo 143-8541, Japan
Takahide Kudo, Kenichi Maruyama, Department of Clinical Functional Physiology, Toho University Medical Center, Omori Hospital, Tokyo 143-8541, Japan
Author contributions: Shiozawa K, Watanabe M and Kikuchi Y designed the study; Kudo T and Maruyama K performed the examination; Shiozawa K and Watanabe M analyzed the data and wrote the manuscript; Sumino Y supervised the study.
Correspondence to: Manabu Watanabe, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Medical Center, Omori Hospital, 6-11-1 Omorinishi, Ota-ku, Tokyo 143-8541, Japan. manabu62@med.toho-u.ac.jp
Telephone: +81-3-37624151 Fax: +81-3-37638542
Received: April 19, 2012
Revised: June 18, 2012
Accepted: July 18, 2012
Published online: October 28, 2012
Revised: June 18, 2012
Accepted: July 18, 2012
Published online: October 28, 2012
Core Tip